|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.050 USD | -8.70% |
|
-22.22% | -82.84% |
| 30/06 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index | CI |
| 29/06 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 3000E Index | CI |
| Market Cap | 2.75Cr 2.41Cr 2.25Cr 2.07Cr 3.88Cr 262.87Cr 3.94Cr 27Cr 10Cr 130.36Cr 10Cr 10Cr 450.41Cr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 2.75Cr 2.41Cr 2.25Cr 2.07Cr 3.88Cr 262.87Cr 3.94Cr 27Cr 10Cr 130.36Cr 10Cr 10Cr 450.41Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
85.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -8.70% | ||
| 1 week | -22.22% | ||
| Current month | -31.37% | ||
| 1 month | -33.54% | ||
| 3 months | -63.79% | ||
| 6 months | -78.87% | ||
| Current year | -82.84% |
| 1 week | 1.05 |  | 1.41 |
| 1 month | 1.05 | | 1.95 |
| Current year | 1.05 | | 7.05 |
| 1 year | 1.05 | | 9.22 |
| 3 years | 1.05 | | 11.99 |
| 5 years | 1.05 | | 11.99 |
| 10 years | 1.05 | | 11.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
CEO | Chief Executive Officer | 64 | 01/03/2015 |
Paul Lytle
DFI | Director of Finance/CFO | 58 | 01/02/2024 |
Steven D. Reich
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
BRD | Director/Board Member | 64 | 01/04/2015 |
Aaron Fletcher
CHM | Chairman | 46 | 01/04/2015 |
Daniel Zabrowski
BRD | Director/Board Member | 66 | 01/03/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 21/05/26 | Free | Director | 15,000 | 0.0633% | ||
| 21/05/26 | Free | Director | 15,000 | 0.0633% | ||
| 21/05/26 | Free | Director | 15,000 | 0.0633% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.70% | -22.22% | -84.69% | - | 2.75Cr | |
| -2.25% | +1.55% | +50.84% | +70.04% | 5.62TCr | |
| -1.32% | -0.97% | +38.41% | +77.52% | 5.48TCr | |
| +1.10% | -0.75% | -18.75% | -14.69% | 2.3TCr | |
| +0.11% | -3.86% | +2.63% | +389.13% | 2.27TCr | |
| -0.21% | +0.84% | +22.48% | -7.92% | 2.02TCr | |
| 0.00% | +3.00% | +27.41% | -29.52% | 1.78TCr | |
| -0.97% | +0.89% | +37.28% | +539.62% | 1.57TCr | |
| -6.69% | -5.11% | +166.00% | +304.89% | 1.52TCr | |
| +1.18% | -0.43% | +25.88% | +181.51% | 1.4TCr | |
| Average | -1.77% | -1.81% | +26.75% | +167.84% | 2.4TCr | |
| Weighted average by Cap. | -1.15% | +0.41% | +37.57% | +131.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | $1.050 | -8.70% | 1,10,923 |
| 27/26/27 | $1.150 | -2.54% | 2,26,824 |
| 24/26/24 | $1.180 | -6.35% | 93,561 |
| 23/26/23 | $1.260 | -0.40% | 1,18,313 |
| 22/26/22 | $1.265 | -6.30% | 1,28,224 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.150USD
Average target price
9.978USD
Spread / Average Target
+767.61%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACTU Stock
Select your edition
All financial news and data tailored to specific country editions
